Abstract
Purpose
Sparse data exist on delirium in VA-ECMO. We aim to describe the characteristics, risk factors, and outcomes of delirium in VA-ECMO.
Methods
We retrospectively reviewed adults’s electronic medical records on VA-ECMO in our ECMO registry in 2016–2022. Delirium was assessed by the Confusion Assessment Method for the intensive care unit when patients scored −3 or above on the Richmond Agitation-Sedation Scale. The primary outcomes were delirium prevalence and the proportion of delirium-present days while on VA-ECMO support. Multivariable logistic regression was used to evaluate delirium risk factors.
Results
Of 208 patients (median [interquartile range] age: 53 [40–62]), 138 (66.3%) had delirium during ECMO. Delirium occurred on day 2.5 [1.0–7.0] of ECMO and was detected in 42% [20%–66%] of ECMO days. There were no differences in acute brain injury (24% vs 33%, p = .34) between patients with and without delirium. Survival analysis showed no significant association between delirium and 30-day mortality (p = .24). In multivariable analysis, ECMO day 1 arterial carbon dioxide partial pressure (adjusted odds ratio [aOR] = 1.29; 95% CI = 1.03–1.73), number of sedatives (aOR = 2.67; 95% CI = 1.68–2.95), and African American race/ethnicity (aOR = 16.45; 95% CI = 9.65–22.51) were associated with delirium.
Conclusions
Delirium was present in 66.3% of VA-ECMO patients and was detected early during ECMO. Modifiable risk factors included multiple sedative agents and early hypercapnia. Delirium did not increase risk for mortality.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
